10times
logo
21 - 22 Apr 2021Ended

Drug Discovery V-Forum

Online  •  Virtual Conference  •  Powered by FLOOR
About30Sessions75Speakers10ExhibitorsReviews3Photos

Official Links

Estimated Turnout

100
Delegates

10 Exhibitors

Editions

Apr 2021

Frequency

Bi-annual
Next edition likely in Oct 2021
Claim event to edit details

Join Us Online for Actionable Science & Virtual Networking! With a 7+ year history of bringing together the global research community to tackle the .. Read more challenges that the discovery sciences face, World BI prides itself on organizing Drug Discovery V-Forum, a fully virtual conference, next year in April. Delivering 2 days of top-level strategic content and the current scientific insights, networking, and discussion from leading global pharmaceuticals, join 100+ attendees to explore the latest trends & strategies within Discovery Research. With senior delegation from top companies all over, you can network with peers from different locations all in one place our online. This fully online event will be a mixture of on-demand and live sessions so you can join the best in class scientific discussions from the comfort of your home office.

Highlights

  • PRECLINICAL TOOLS & MODELING IN ONCOLOGY
  • BIOLOGICS DRUG DISCOVERY
  • ADVANCES IN DRUG DESIGN
  • AI IN DRUG DISCOVERY
Filter By
Registration
Online Registration

Opening Ceremony
Welcome from the Chair
Tomi Sawyer
Tomi Sawyer Chief Drug Hunter & President, Maestro Therap..
Shruthi Bharadwaj, Ph.D
Shruthi Bharadwaj, Ph.D Data Science & A.I Advisor, Chief Digital Off..

Session
The Drug Discovery and Development Process is Ineffective and Extremely Expensive, Is there Room for Optimization?
Domingo Gargallo-Viola
Domingo Gargallo-Viola CEO, CSO, ABAC Therapeutics S.L.
Tomi Sawyer
Tomi Sawyer Chief Drug Hunter & President, Maestro Therap..

Session
Rethinking Peptide Drug Design: The Past, Present and Future
Tomi Sawyer
Tomi Sawyer Chief Drug Hunter & President, Maestro Therap..

Session
Drug Screening Platforms for Targeting SARS-CoV-2 Entry and Processing
To support the drug discovery community in the challenge to identify efficacious COVID-19 drugs, Reaction Biology has developed spec
Rebecca Eells, PhD
Rebecca Eells, PhD Director of Biophysics, Reaction Biology
Tomi Sawyer
Tomi Sawyer Chief Drug Hunter & President, Maestro Therap..

Session
An Introduction to Attana and How we Revolutionize the Drug Development Process
Shruthi Bharadwaj, Ph.D
Shruthi Bharadwaj, Ph.D Data Science & A.I Advisor, Chief Digital Off..
Teodor Aastrup
Teodor Aastrup CEO, Attana

Session
INTERACTIVE PANEL: AI Driven Drug Discovery Models: A Paradigm Shift
Shruthi Bharadwaj, Ph.D
Shruthi Bharadwaj, Ph.D Data Science & A.I Advisor, Chief Digital Off..
Rafael Depetris
Rafael Depetris Principal Scientist II, Lead of Structure Bas..

Session
Data and Advanced Analytics Driving Innovation within Healthcare The Future of Data Science and A.I Across the Life Science Value Chain
Shruthi Bharadwaj, Ph.D
Shruthi Bharadwaj, Ph.D Data Science & A.I Advisor, Chief Digital Off..

Session
Three pillars for ART-ificial Intelligence in Drug Design
Hideyoshi Fuji
Hideyoshi Fuji Manager, Astellas Pharma
Shruthi Bharadwaj, Ph.D
Shruthi Bharadwaj, Ph.D Data Science & A.I Advisor, Chief Digital Off..

Session
AI in the Development of Novel Therapies Against Inflammatory Diseases
Philippe Moingeon
Philippe Moingeon Head of Therapeutic Area Immuno-Inflammation,..
Shruthi Bharadwaj, Ph.D
Shruthi Bharadwaj, Ph.D Data Science & A.I Advisor, Chief Digital Off..

Session
Preclinical Models to Evaluate Potent Off-the-Shelf Combination Treatment for T cell Redirection Against Tumors
Sara Colombetti
Sara Colombetti Global Head of Oncology Discovery Pharmacolog..
Shruthi Bharadwaj, Ph.D
Shruthi Bharadwaj, Ph.D Data Science & A.I Advisor, Chief Digital Off..

Closing Ceremony
Closing Remarks
Shruthi Bharadwaj, Ph.D
Shruthi Bharadwaj, Ph.D Data Science & A.I Advisor, Chief Digital Off..

Registration
Online Registration

Opening Ceremony
Welcome from the Chair
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm

Session
Giving New Life to Old Drugs 505(b)(2) Route
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm

Session
The COVID Moonshot: From Fragments to Clinic for the Pandemic
Frank von Delft
Frank von Delft Professor of Structural Chemical Biology, Uni..
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm

Session
The Next Generation of Biological Therapeutics A Systematic Review
Rajkumar Ganesan
Rajkumar Ganesan Director – Antibody Engineering (Bispecifics ..
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm

Session
Reprogramming Macrophages into their Homeostatic State: Cell Based Therapeutic for Life-Threatening Indications
Oren Herhskovitz
Oren Herhskovitz CEO, Enlivex Therapeutics
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm

Session
Achieving an Antibody Drug Candidate: Advances in Biologics Drug Discovery
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm
Caroline Barelle
Caroline Barelle Chief Executive Officer and Founder, Elasmoge..

Session
Advancing Glycan Mediated Therapy
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm
Manuela Mally
Manuela Mally Director, Head of Research, GlycoEra AG

Session
Systematic Discovery Identifies 4CB-1, A Novel Anti-HVEM Monoclonal Antibody that Enhances the Anti-Tumor Activity of Immune Cells
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm
Eyal Greenberg, Ph.D., MBA
Eyal Greenberg, Ph.D., MBA Chief Executive Officer, 4C Biomed Services L..

Session
A Cell-Based Intracellular Antibody-Guided Screening Method for Discovering Small Molecules
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm
Nicolas BERY
Nicolas BERY Senior Postdoctoral Scientist, Cancer Researc..

Session
MuTaTo- a novel concept for curing cancer
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm
Dan D. Aridor
Dan D. Aridor Chairman of the Board, AEBI-Bio

Session
Discovery to IND Lessons learned
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm
Idit Eshkar-Oren
Idit Eshkar-Oren Director Non-Clinical Safety, Pi Therapeutics

Session
Advances in Drug Design! The GABAA Receptor as a Drug Target: Past, Present and Future
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm
Dr Michael-Robin Witt
Dr Michael-Robin Witt CEO, Gabather

Session
Tag-Team Presentation: DNA-Encoded Chemical Libraries as a Versatile and Powerful Tool Towards Innovative Therapeutic Applications
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm
Etienne Donckele
Etienne Donckele Senior Scientist - Deputy Head of Chemistry, ..

Session
Understanding the Robustness and Limitations of Primary Epithelial Models in Drug Discovery: A Focus on Gut Organoids
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm
Linda A. Lieberman
Linda A. Lieberman Principal Scientist, Merck

Session
From Microbiome to Human Health: Finding Disease Markers in the Metagenomic Data
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm
Iddo Weiner
Iddo Weiner Director, Head of Software, BiomX

Session
Data-Driven Computational Analysis and Simulation Identified Drug Repurposing Opportunities for COVID-19
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm
Namshik Han, PhD
Namshik Han, PhD Head of Artificial Intelligence, Milner Thera..

Closing Ceremony
Closing Remarks
Elana Hariton Gazal
Elana Hariton Gazal Head of Pharmaceutical Research, Neuroderm

Speaker
Sara Colombetti

Sara Colombetti

Global Head of Oncology Discovery Pharmacology, Roche Innovation Center...
Speaker
Rajkumar Ganesan

Rajkumar Ganesan

Director – Antibody Engineering (Bispecifics and CAR-T), The Janssen Pharmaceutical...
Speaker
Tomi Sawyer

Tomi Sawyer

Chief Drug Hunter & President, Maestro Therapeutics
Speaker
Shruthi Bharadwaj, Ph.D

Shruthi Bharadwaj, Ph.D

Data Science & A.I Advisor, Chief Digital Office, NovartisBengaluru, India
Free Delegates
999 GBP Participant
  • Followers
  • [ Users who have shown interest for this Event ]
Simon A. Larsen

Simon A. Larsen

Director, Client Relations at evitria AG

Zürich, Switzerland
Nicolas BERY

Nicolas BERY

Senior Postdoctoral Scientist at Cancer Research Centre of Toulouse (CRCT)

Toulouse, France
Wenlong Tang

Wenlong Tang

Data Sciences Solutions Mgr at Takeda

Cambridge, United States
Mogens Nielsen

Mogens Nielsen

Board Member at Gabather AB

Roskilde, Denmark
  • Share your Experience
  • Organizer
Logo Follow Company

World BI Limited Top Rated

UK40 Total Events / 13 Upcoming Events

More Events From The Organizer

  • Sponsors
Sponsor
profile

Reaction Biology Corporation

Main SponsorUSA

Sponsor
profile

Attana AB

Main SponsorSweden

Sponsor
profile

e-Zyvec : DNA vector made easy

Co-Sponsor

Sponsor
profile

evitria AG

Co-Sponsor

Sponsor
profile

Admescope

Co-SponsorFinland

Sponsor
profile

Selvita S.A.

Co-SponsorSwitzerland

You have no contacts. Please add contacts from below or share on social media

Send to all
No Results